From start up to multinational, we help you understand all the internal and external strategic processes required for success.
Sucessful market access needs good process, so we help you identify and link the following benefits:
– Benefits to patients
– Benefits to care providers
– Benefits to payers (CCGs)
We supportyour product development
We support your R&D process; development of evidence to support the HTA and NICE processes, safety and efficacy and cost effectiveness being linked to the likelihood of success.
We analyse your evidence and perform gap analysis to ensure you understand and obtain the right evidence requirements for the HTA journey ahead.
We supportyour product launch process and strategy
We support your commercial launch process; preparing your technology for the market, preparing your company for launching the technology and preparing the market for your technology.
Through our access to real-time patient pathway analysis, we can help you engage differently to become a solution provider to the NHS.
We supportyour National Market Access strategy
The NHS has processes at national level, which may include NICE Interventional Procedure (IP) approval to demonstrate safety and efficacy as well as programmes that help promote individually branded new and innovative treatments to the NHS through the Medical Technologies Programmes (MTG)
With years of successful NICE engagement and 24 approvals, we help you to engage early and understand the requirements for a successful NICE outcome.
We supportyour local Market Access
We can help with approval at individual hospital level, through initial clinician engagement and support with hospital approval committees.
We develop bespoke business cases and ‘How To’ guides, allowing you to engage with key hospital decision makers and become a trusted solution provider through your technology.